Role of serial polio seroprevalence studies in guiding implementation of the polio eradication initiative in Kano, Nigeria: 2011-2014

11Citations
Citations of this article
90Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background. Nigeria was one of 3 polio-endemic countries before it was de-listed in September 2015 by the World Health Organization, following interruption of transmission of the poliovirus. During 2011-2014, Nigeria conducted serial polio seroprevalence surveys (SPS) in Kano Metropolitan Area, comprising 8 local government areas (LGAs) in Kano that is considered very high risk (VHR) for polio, to monitor performance of the polio eradication program and guide the program in the adoption of innovative strategies. Methods. Study subjects who resided in any of the 8 local government areas of Kano Metropolitan Area and satisfied age criteria were recruited from patients at Murtala Mohammed Specialist Hospital (Kano) for 3 seroprevalence surveys. The same methods were used to conduct each survey. Results. The 2011 study showed seroprevalence values of 81%, 75%, and 73% for poliovirus types 1, 2, and 3, respectively, among infants aged 6-9 months age. Among children aged 36-47 months, seroprevalence values were greater (91%, 87%, and 85% for poliovirus types 1, 2, and 3, respectively). In 2013, the results showed that the seroprevalence was unexpectedly low among infants aged 6-9 months, remained high among children aged 36-47 months, and increased minimally among children aged 5-9 years and those aged 10-14 years. The baseline seroprevalence among infants aged 6-9 months in 2014 was better than that in 2013. Conclusions. The results from the polio seroprevalence surveys conducted in Kano Metropolitan Area in 2011, 2013, and 2014 served to assess the trends in immunity and program performance, as well as to guide the program, leading to various interventions being implemented with good effect, as evidenced by the reduction of poliovirus circulation in Kano.

References Powered by Scopus

Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: A randomised, double-blind, controlled trial

138Citations
N/AReaders
Get full text

Perspectives on polio and immunization in Northern Nigeria

128Citations
N/AReaders
Get full text

Outbreak of type 2 vaccine-derived poliovirus in Nigeria: Emergence and widespread circulation in an underimmunized population

100Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Polio immunity and the impact of mass immunization campaigns in the Democratic Republic of the Congo

18Citations
N/AReaders
Get full text

Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria

9Citations
N/AReaders
Get full text

Seroprevalence of anti-polio antibodies in children from polio high risk area of Afghanistan: A cross sectional survey 2017

8Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Craig, K. T. O., Verma, H., Iliyasu, Z., Mkanda, P., Touray, K., Johnson, T., … Vaz, R. G. (2016). Role of serial polio seroprevalence studies in guiding implementation of the polio eradication initiative in Kano, Nigeria: 2011-2014. Journal of Infectious Diseases, 213, S124–S130. https://doi.org/10.1093/infdis/jiv774

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 33

59%

Researcher 18

32%

Professor / Associate Prof. 4

7%

Lecturer / Post doc 1

2%

Readers' Discipline

Tooltip

Medicine and Dentistry 29

58%

Nursing and Health Professions 11

22%

Social Sciences 6

12%

Biochemistry, Genetics and Molecular Bi... 4

8%

Article Metrics

Tooltip
Mentions
News Mentions: 2
Social Media
Shares, Likes & Comments: 1

Save time finding and organizing research with Mendeley

Sign up for free